These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1759393)

  • 1. [Irreversible pH-denaturation of tissue thromboplastin].
    Zubairov DM; Svintenok GIu; Chenborisova GSh
    Vopr Med Khim; 1991; 37(5):31-3. PubMed ID: 1759393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients.
    Meng ZH; Wolberg AS; Monroe DM; Hoffman M
    J Trauma; 2003 Nov; 55(5):886-91. PubMed ID: 14608161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular structure and function of tissue thromboplastin and thromboplastin inhibitor, calphobindin in blood coagulation and fibrinolysis].
    Shidara Y; Takahashi O; Murata M; Kume K; Narita M; Sato H; Sato Y; Higuchi M; Maki M
    Nihon Rinsho; 1989 Apr; 47(4):844-50. PubMed ID: 2526262
    [No Abstract]   [Full Text] [Related]  

  • 4. [Progresses in the study of platelet membrane phospholipid stimulation of procoagulant activity].
    Zhou R; Bao C
    Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):494-6. PubMed ID: 11189489
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of factor IX in tissue thromboplastin induced coagulation.
    van den Besselaar AM; Ram IE; Alderkamp GH; Bertina RM
    Thromb Haemost; 1982 Aug; 48(1):54-8. PubMed ID: 6982540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The critical evaluation of thromboplastin.
    Ziegler FD; Kelly JH
    Ann Clin Lab Sci (1971); 1972; 2(1):16-25. PubMed ID: 4563046
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of radiation sickness on tissue thromboplastin activity].
    Zubairov DM; Gritsuk GN; Vladimirova LF; Anisimova VF
    Radiobiologiia; 1970; 10(3):432-4. PubMed ID: 5451517
    [No Abstract]   [Full Text] [Related]  

  • 8. Thermal denaturation of human gamma-interferon. A calorimetric and spectroscopic study.
    Beldarrain A; López-Lacomba JL; Furrazola G; Barberia D; Cortijo M
    Biochemistry; 1999 Jun; 38(24):7865-73. PubMed ID: 10387027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phospholipids and various blood coagulation problems in experimental thrombosis].
    Karagezian KG; Ovakimian SS; Mirza-Avakian GL
    Vopr Med Khim; 1970; 16(5):503-8. PubMed ID: 5523766
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of thromboplastin apoprotein of different tissues with concanavalin A--evidence for heterogeneous glycosylation of the human apoprotein.
    van den Besselaar AM; Bertina RM
    Thromb Haemost; 1984 Oct; 52(2):192-5. PubMed ID: 6441304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII.
    Iino M; Foster DC; Kisiel W
    Arch Biochem Biophys; 1998 Apr; 352(2):182-92. PubMed ID: 9587405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of prothrombinase activity by protein S.
    van 't Veer C; Butenas S; Golden NJ; Mann KG
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coextraction of thrombomodulin and tissue factor from human placenta: effects of concanavalin A and phospholipid environment on activity.
    Freyssinet JM; Brami B; Gauchy J; Cazenave JP
    Thromb Haemost; 1986 Feb; 55(1):112-8. PubMed ID: 3010487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modification effect of the protein component of tissue thromboplastin (factor III) on its interaction with factors VII and X].
    Zubairov DM; Baĭkeev RF; Byshevskiĭ ASh; Tersenov OA
    Biokhimiia; 1984 Jun; 49(6):971-5. PubMed ID: 6466743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel surface modification using tissue factor reconstituted in phospholipid vesicles for the activation of blood coagulation.
    Svedhem S; Wikström A; Deinum J; Kasemo B; Hansson K
    J Biomater Sci Polym Ed; 2009; 20(1):133-40. PubMed ID: 19105905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid activation of coagulation factor III apoprotein (tissue factor)--reconstitution of the protein-membrane complex.
    Carson SD; Konigsberg WH
    Thromb Haemost; 1980 Aug; 44(1):12-5. PubMed ID: 7423440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
    Hathcock JJ; Rusinova E; Andree H; Nemerson Y
    Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
    Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
    Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant properties of rabbit lungs in tissue thromboplastin-induced intravascular coagulation.
    Vad H; Tvedskov TF; Hansen KB; Albrechtsen OK; Jespersen J; Gram J
    Thromb Haemost; 1997 Apr; 77(4):679-84. PubMed ID: 9134642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes of the blood-pH and coagulation potential (author's transl)].
    Neef H; Richter M; Fischer U
    Anaesthesist; 1974 Mar; 23(3):158-61. PubMed ID: 4460739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.